ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617076 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617076; 2) Community: the network communities that were significantly associated with the response to NSC 617076; 3) Molecule: the relationships between components within communities and NSC 617076; 4) MDR: the compounds that were significantly associated with the NSC 617076.

NSC Compound Enrichment Correlation
NSC 137765 Ethanesulfonic acid, compd. with 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-N-phenylbenzeneacetamide (1:1) 0.00209154338952976 0.16106418
NSC 172599 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- 0.00209154338952976 0.19999156
NSC 357680 BUELLOLIDE 0.00209154338952976 0.24622444
NSC 679024 1,8-Naphthyridin-4(1H)-one, 2-(4-fluorophenyl)-5-methyl- 0.00243861794188205 0.21286769
NSC 682996 Null 0.00243861794188205 0.30988245
NSC 325268 Null 0.00243861794188209 0.18559129
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.00243861794188209 0.23860981
NSC 12198 Dromostanolone Propionate 0.00264567501902517 0.18799776
NSC 169774 Bromocriptine methanesulfonate 0.00264567501902517 0.039980805
NSC 317908 Null 0.00264567501902517 0.14687586
Total:94  Current:10    [First] [Prev] [Next] [Last]